Structures by: Şekerci M.
Total: 23
4-Benzyl-3-(2-hydroxyphenyl)-1H-1,2,4-triazole-5(4H)-thione
C15H13N3O1S1
Acta Crystallographica Section E (2004) 60, 10 o1883-o1885
a=5.7387(5)Å b=23.842(3)Å c=10.3045(9)Å
α=90.00° β=104.655(7)° γ=90.00°
1-amino-5-benzoyl-4-phenylpyrimidin-2(1H)-one
C17H13N3O2
Acta Crystallographica Section E (2004) 60, 12 o2476-o2478
a=11.7547(11)Å b=16.6566(11)Å c=7.2986(6)Å
α=90.00° β=101.722(7)° γ=90.00°
3-Benzyl-4-(4-methylphenyl)-1H-1,2,4-triazole-5(4H)-thione
C16H15N3S
Acta Crystallographica Section E (2004) 60, 12 o2281-o2283
a=12.3833(12)Å b=7.2297(5)Å c=15.8926(15)Å
α=90° β=95.488(7)° γ=90°
4-Allyl-2-(morpholin-4-ylmethyl)-5-(pyridin-4-yl)-2,4-dihydro-3H-1,2,4- triazole-3-thione
C15H19N5OS
Acta Crystallographica Section E (2005) 61, 6 o1953-o1955
a=8.9387(7)Å b=9.1043(7)Å c=10.6069(8)Å
α=88.509(6)° β=85.498(6)° γ=80.661(6)°
1-[2-(1,3-Benzothiazol-2-ylimino)imidazolidin-1-yl]ethanone
C12H12N4OS
Acta Crystallographica Section E (2006) 62, 5 o1870-o1871
a=7.31240(10)Å b=7.93120(10)Å c=21.0085(3)Å
α=90° β=93.2710(10)° γ=90°
4-(4-Chlorophenyl)-3-(furan-2-yl)-1H-1,2,4-triazole-5(4H)-thione
C12H8ClN3OS
Acta Crystallographica Section E (2004) 60, 3 o425-o427
a=8.524(5)Å b=8.640(5)Å c=9.307(5)Å
α=91.426(5)° β=90.250(5)° γ=116.059(5)°
3-Benzyl-4-(4-chlorophenyl)-1H-1,2,4-triazole-5(4H)-thione
C15H12ClN3S
Acta Crystallographica Section E (2004) 60, 4 o642-o644
a=9.181(5)Å b=17.803(5)Å c=9.231(5)Å
α=90° β=108.882(5)° γ=90°
3-(2-Hydroxyphenyl)-4-phenyl-1H-1,2,4-triazole-5(4H)-thione
C14H11N3OS
Acta Crystallographica Section E (2004) 60, 9 o1580-o1582
a=5.7333(4)Å b=19.1695(16)Å c=11.6547(8)Å
α=90.00° β=103.441(6)° γ=90.00°
N-Phenyl-N'-(thiophen-2-ylmethylene)hydrazine
C11H10N2S
Acta Crystallographica Section E (2004) 60, 9 o1552-o1553
a=6.0473(6)Å b=7.4417(7)Å c=22.376(3)Å
α=90.00° β=90.00° γ=90.00°
5-Benzyl-4-phenyl-2,4-dihydro-1,2,4-triazole-3-thione
C15H13N3S
Acta Crystallographica Section E (2004) 60, 9 o1507-o1509
a=7.0467(5)Å b=17.6802(13)Å c=11.2725(7)Å
α=90° β=104.355(5)° γ=90°
4-Phenyl-3-(pyridin-4-yl)-1H-1,2,4-triazole-5(4H)-thione
C13H10N4S
Acta Crystallographica Section E (2005) 61, 3 o619-o621
a=11.2958(6)Å b=12.7480(8)Å c=17.5607(8)Å
α=90° β=90° γ=90°
5-Phenyl-1,3,4-thiadiazol-2-amine
C8H7N3S
Acta Crystallographica Section E (2004) 60, 5 o820-o821
a=10.604(5)Å b=7.922(5)Å c=11.116(5)Å
α=90° β=117.965(5)° γ=90°
5-Furan-2-yl-1,3,4-oxadiazole-2(3H)-thione
C6H4N2O2S
Acta Crystallographica Section E (2004) 60, 3 o322-o323
a=5.194(5)Å b=20.102(5)Å c=6.914(5)Å
α=90° β=102.573(5)° γ=90°
5-Furan-2-yl-4-p-tolyl-2,4-dihydro-1,2,4-triazole-3-thione
C13H11N3O1S1
Acta Crystallographica Section E (2004) 60, 8 o1405-o1407
a=8.5665(15)Å b=8.7759(16)Å c=9.5372(17)Å
α=91.796(15)° β=91.407(14)° γ=116.386(12)°
5-(2-Hydroxyphenyl)-4-(p-tolyl)-2,4-dihydro-1,2,4-triazole-3-thione
C15H13N3OS
Acta Crystallographica, Section E (2004) 60, 8 o1339-o1341
a=26.524(3)Å b=11.3288(18)Å c=9.2310(11)Å
α=90.00° β=104.643(9)° γ=90.00°
5-(2-Furyl)-4-(4-methoxyphenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione
C13H11N3O2S
Acta Crystallographica Section E (2004) 60, 12 o2368-o2370
a=7.0789(6)Å b=8.4650(6)Å c=21.4774(13)Å
α=90° β=96.492(5)° γ=90°
4-Ethyl-5-(2-hydroxyphenyl)-2H-1,2,4-triazole-3(4H)-thione
C10H11N3OS
Acta Crystallographica Section E (2005) 61, 1 o17-o19
a=9.7879(8)Å b=7.9071(5)Å c=13.8045(10)Å
α=90.00° β=102.266(6)° γ=90.00°
4-Amino-5-(2-hydroxyphenyl)-2H-1,2,4-triazole-3(4H)-thione
C8H8N4OS
Acta Crystallographica Section E (2005) 61, 10 o3214-o3216
a=12.0231(19)Å b=5.7685(8)Å c=14.434(2)Å
α=90° β=114.393(11)° γ=90°
N-(4-Chlorophenyl)-N-(4,5-dihydro-1H-imidazol-2-yl)amine formamide solvate
C9H10ClN3,CH3NO
Acta Crystallographica Section E (2007) 63, 5 o2130-o2132
a=8.5840(5)Å b=13.2740(4)Å c=9.9080(7)Å
α=90° β=105.789(5)° γ=90°
(1,3-Benzothiazol-2-yl)[1-(2-chlorobenzyl)imidazolidin-2-ylidene]amine
C17H15ClN4S
Acta Crystallographica Section E (2006) 62, 9 o3812-o3813
a=20.0595(3)Å b=10.6269(2)Å c=15.0647(2)Å
α=90° β=97.5720(10)° γ=90°
Dimethyl N-(4-phenyl-1,3-thiazol-2-yl)dithioimidocarbonate
C12H12N2S3
Acta Crystallographica Section E (2006) 62, 9 o3902-o3903
a=7.66260(10)Å b=18.2969(3)Å c=19.4176(3)Å
α=90° β=90° γ=90°
1,3-Bis(2-chlorobenzoyl)-3,4,5,6-tetrahydropyrimidine-2(1H)-thione
C18H14Cl2N2O2S
Acta Crystallographica Section E (2006) 62, 9 o3697-o3698
a=11.361(5)Å b=12.917(5)Å c=12.186(5)Å
α=90° β=95.399(5)° γ=90°
(<i>E</i>)-5-Phenyl-<i>N</i>-(2-thienylmethylene)-1,3,4-thiadiazole-2-amine
C13H9N3S2
Acta Crystallographica Section E (2009) 65, 7 o1668
a=6.2238(3)Å b=7.7393(3)Å c=25.6959(13)Å
α=90.00° β=94.701(4)° γ=90.00°